Staging of Head and Neck Squamous Cell Cancer with Extended-Field FDG-PET

Archives of Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 11, 2003, Pages 1173-1178

  Schwartz, David L ^a   Rajendran, Joseph ^b   Yueh, Bevan ^b   Coltrera, Marc ^b   Anzai, Yoshimi ^a   Krohn, Kenneth ^b   Eary, Janet ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GASTROINTESTINAL DISEASE; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CARCINOMA; LIVER FUNCTION TEST; LIVER METASTASIS; MALE; MEDIASTINUM METASTASIS; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VISCERAL METASTASIS;

CARCINOMA, SQUAMOUS CELL; DIGESTIVE SYSTEM NEOPLASMS; FEASIBILITY STUDIES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0242576327     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.129.11.1173     Document Type: Article

References (27)

1. Vokes EE, Weichselbaum RR, Lippman SM, Others. Head and neck cancer. N Engl J Med. 1993;328:184-194.
2. Dennington ML, Carter DR, Meyers AD. Distant metastases in head and neck epidermoid carcinoma. Laryngoscope. 1980;90:196-201.
3. Black RJ, Gluckman JL, Shumrick DA. Screening for distant metastases in head and neck cancer patients. Aust N Z J Surg. 1984;54:527-30.
4. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995;75:1343-1353.
5. Massard G, Roeslin N, Jung GM, Dumont P, Wihlm JM, Morand G. Bronchogenic cancer associated with head and neck tumors: survival analysis of 194 patients. J Thorac Cardiovasc Surg. 1993;106:218-227.
6. Schwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994;74:1933-1938.
7. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer. 1993;71:452-456.
8. Houghton DJ, Hughes ML, Garvey C, et al. Role of chest CT scanning in the management of patients presenting with head and neck cancer. Head Neck. 1998;20:614-618.
9. Korver KD, Graham SM, Hoffman HT, McCulloch T, Funk GF. Liver function studies in the assessment of head and neck cancer patients. Head Neck. 1995;17:531-534.
10. Wax MK, Myers LL, Gabalski EC, Husain S, Gona JM, Nabi H. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002;128:703-707.
11. Belson TP, Lehman RH, Chobanian SL, Malin TC. Bone and liver scans in patients with head and neck carcinoma. Laryngoscope. 1980;90:1291-1296.
12. de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope. 2000;110:397-401.
13. Nishijima W, Takooda S, Tokita N, Takayama S, Sakura M. Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch Otolaryngol Head Neck Surg. 1993;119:65-68.
14. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer. 1994;73:3047-3058.
15. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med. 1995;36:1747-1757.
16. Teknos TN, Rosenthal EL, Lee D, Taylor R, Marn CS. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck. 2001;23:1056-1060.
17. Braams JW, Pruim J, Freling NJ, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med. 1995;36:211-216.
18. Bailet JW, Sercarz JA, Abemayor E, Anzai Y, Lufkin RB, Hoh CK. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope. 1995;105:135-139.
19. Lowe VJ, Kim H, Boyd JH, Eisenbeis JF, Dunphy FR, Fletcher JW. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging. Radiology. 1999;212:799-802.
20. Brun E, Kjellen E, Tennvall J, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002;24:127-135.
21. Maisey MN. Overview of clinical PET. Br J Radiol. 2002;75:S1-S5.
22. Shih WJ, Han JK, Coupal J, Wierzbinski B, Magoun S, Gross K. Axillary lymph node uptake of Tc-99m MIBI resulting from extravasation should not be misinterpreted as metastasis. Ann Nucl Med. 1999;13:269-271.
23. Taneja C, Allen H, Koness RJ, Radie-Keane K, Wanebo HJ. Changing patterns of failure of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002;128:324-327.
24. Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol. 2001;19:1961-1969.
25. Adelstein DJ, Saxton JP, Lavertu P, et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol. 2002;20:1405-1410.
26. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-1608.
27. Pfister DG, Wells CK, Chan CK, Feinstein AR. Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy. Cancer Res. 1990;50:4664-4669.